DailyDoctor Archive Specialties Get app
All urology briefings

The edition · Urology

A suction sheath changed the numbers in infected stone surgery

185 patients randomised: lower white cell count, CRP and procalcitonin at six and 24 hours, higher stone-free rates, shorter operating time and fewer complications with a flexible negative-suction access sheath. Plus PSA screening reaches high-certainty evidence at 11 to 23 years, and abiraterone turns out to reduce fractures in metastatic disease, not cause them.

The edition in brief

Two findings today reverse an assumption. A randomised trial in 185 patients with infectious upper urinary tract stones compared flexible ureteroscopy using a flexible negative-suction ureteral access sheath against a traditional sheath. The suction group had lower white cell count, C-reactive protein and procalcitonin at both six and 24 hours after surgery, higher stone-free rates on day one and at 30 days, shorter operating time, shorter stay, better quality of life and a lower overall complication rate. Ureteral stricture at three months did not differ. Separately, a secondary analysis within the STAMPEDE platform linked 3,102 English patients to hospital episode data and found that abiraterone-based intensification did not increase fracture-related hospitalisation as earlier meta-analyses had suggested. In metastatic disease it reduced it: five-year incidence 22% versus 30% with abiraterone added (subdistribution hazard ratio 0.77, 95% CI 0.59 to 0.99) and 28% versus 38% with abiraterone plus enzalutamide (0.69, 0.54 to 0.88). There was no difference in non-metastatic disease. A meta-analysis of 5 randomised trials and 721,607 participants followed for 11 to 23 years found high-certainty evidence that PSA-based screening reduces prostate cancer-specific mortality among those who engage in it, with a larger relative reduction the longer the follow-up — while stating that this does not by itself justify population screening. The AUA and SUO have updated their non-muscle-invasive bladder cancer guideline, and Class II recalls have been issued for mirabegron tablets and for sildenafil and tadalafil compounding powders.

In this edition
01Practice changer

Negative-suction access sheath lowered the inflammatory response after infected stone surgery

A flexible negative-suction ureteral access sheath lowered white cell count, CRP and procalcitonin at six and 24 hours and raised stone-free rates in infected upper tract stones — the population most at risk of post-operative sepsis.

2 min · UrolithiasisRead →
02Clinical update

PSA screening now has high-certainty evidence — and still does not settle the policy question

High-certainty evidence from 5 trials and 721,607 men followed 11 to 23 years shows PSA-based screening reduces prostate cancer death among those screened — which changes the counselling conversation without settling whether to screen a population.

2 min · European urologyRead →
03Clinical update

Abiraterone reduced fracture hospitalisation in metastatic disease rather than causing it

Abiraterone-based intensification did not raise fracture hospitalisation and in metastatic disease reduced it, from 30% to 22% at five years — fracture risk is not a reason to withhold it.

2 min · European urologyRead →
04Regulatory

Mirabegron and compounding-grade sildenafil and tadalafil recalled; new AUA guideline for NMIBC

Class II recalls affect mirabegron 25 mg tablets and bulk sildenafil and tadalafil compounding powder; separately, the AUA and SUO have revised NMIBC risk stratification and their statements on intravesical therapy and BCG maintenance.

2 min · The Journal of urologyRead →
05Research

Real-world data ranks the mHSPC doublets — with the usual caveat

Real-world data across 18,626 patients favoured apalutamide over abiraterone on survival and PSA response but favoured abiraterone on tolerability — retrospective evidence that should not override cost, comorbidity or a stable regimen.

2 min · BJU internationalRead →
06Pearl

Drain the obstructed infected kidney today; the stone can wait a month

In an obstructed infected kidney, decompress within hours and treat the stone weeks later — and send a culture from the collecting system, not just the bladder.

2 minRead →

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for urology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free